Pfizer reported that its mRNA flu shot outperformed conventional flu vaccines in a Phase 3 trial, but independent experts told The Defender the company’s study overstates the benefits and downplays safety signals. They cited flaws in the Pfizer-funded research, including missing data that call into question the trial’s conclusions.

https://childrenshealthdefense.org/defender/pfizer-claims-victory-mrna-flu-shot-critics-flaws-safety-signals/?